BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 16820561)

  • 1. Living autologous heart valves engineered from human prenatally harvested progenitors.
    Schmidt D; Mol A; Breymann C; Achermann J; Odermatt B; Gössi M; Neuenschwander S; Prêtre R; Genoni M; Zund G; Hoerstrup SP
    Circulation; 2006 Jul; 114(1 Suppl):I125-31. PubMed ID: 16820561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.
    Weber B; Zeisberger SM; Hoerstrup SP
    Placenta; 2011 Oct; 32 Suppl 4():S316-9. PubMed ID: 21575988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source.
    Schmidt D; Achermann J; Odermatt B; Breymann C; Mol A; Genoni M; Zund G; Hoerstrup SP
    Circulation; 2007 Sep; 116(11 Suppl):I64-70. PubMed ID: 17846327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
    Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
    Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering.
    Schmidt D; Achermann J; Odermatt B; Genoni M; Zund G; Hoerstrup SP
    J Heart Valve Dis; 2008 Jul; 17(4):446-55; discussion 455. PubMed ID: 18751475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
    Hoerstrup SP; Kadner A; Melnitchouk S; Trojan A; Eid K; Tracy J; Sodian R; Visjager JF; Kolb SA; Grunenfelder J; Zund G; Turina MI
    Circulation; 2002 Sep; 106(12 Suppl 1):I143-50. PubMed ID: 12354724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
    Engelmayr GC; Sales VL; Mayer JE; Sacks MS
    Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells.
    Schmidt D; Mol A; Neuenschwander S; Breymann C; Gössi M; Zund G; Turina M; Hoerstrup SP
    Eur J Cardiothorac Surg; 2005 May; 27(5):795-800. PubMed ID: 15848316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
    Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
    Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts.
    Schmidt D; Breymann C; Weber A; Guenter CI; Neuenschwander S; Zund G; Turina M; Hoerstrup SP
    Ann Thorac Surg; 2004 Dec; 78(6):2094-8. PubMed ID: 15561042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human umbilical cord cells for cardiovascular tissue engineering: a comparative study.
    Kadner A; Zund G; Maurus C; Breymann C; Yakarisik S; Kadner G; Turina M; Hoerstrup SP
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):635-41. PubMed ID: 15037283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered living blood vessels: functional endothelia generated from human umbilical cord-derived progenitors.
    Schmidt D; Asmis LM; Odermatt B; Kelm J; Breymann C; Gössi M; Genoni M; Zund G; Hoerstrup SP
    Ann Thorac Surg; 2006 Oct; 82(4):1465-71; discussion 1471. PubMed ID: 16996955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous human tissue-engineered heart valves: prospects for systemic application.
    Mol A; Rutten MC; Driessen NJ; Bouten CV; Zünd G; Baaijens FP; Hoerstrup SP
    Circulation; 2006 Jul; 114(1 Suppl):I152-8. PubMed ID: 16820565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
    Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP
    J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells.
    Schmidt D; Mol A; Odermatt B; Neuenschwander S; Breymann C; Gössi M; Genoni M; Zund G; Hoerstrup SP
    Tissue Eng; 2006 Nov; 12(11):3223-32. PubMed ID: 17518636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From stem cells to viable autologous semilunar heart valve.
    Sutherland FW; Perry TE; Yu Y; Sherwood MC; Rabkin E; Masuda Y; Garcia GA; McLellan DL; Engelmayr GC; Sacks MS; Schoen FJ; Mayer JE
    Circulation; 2005 May; 111(21):2783-91. PubMed ID: 15927990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
    Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
    Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
    Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
    Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates.
    Weber B; Scherman J; Emmert MY; Gruenenfelder J; Verbeek R; Bracher M; Black M; Kortsmit J; Franz T; Schoenauer R; Baumgartner L; Brokopp C; Agarkova I; Wolint P; Zund G; Falk V; Zilla P; Hoerstrup SP
    Eur Heart J; 2011 Nov; 32(22):2830-40. PubMed ID: 21415068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model.
    Flanagan TC; Sachweh JS; Frese J; Schnöring H; Gronloh N; Koch S; Tolba RH; Schmitz-Rode T; Jockenhoevel S
    Tissue Eng Part A; 2009 Oct; 15(10):2965-76. PubMed ID: 19320544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.